Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | calcium channel, voltage-dependent, T type, alpha 1H subunit | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Homo sapiens | arachidonate 15-lipoxygenase | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | arachidonate 5 lipoxygenase | arachidonate 15-lipoxygenase | 662 aa | 590 aa | 23.9 % |
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | lipoxygenase | 0.0067 | 0.0522 | 0.0522 |
Giardia lamblia | Pyruvate kinase | 0.0319 | 0.4833 | 0.1633 |
Echinococcus multilocularis | pyruvate kinase | 0.0319 | 0.4833 | 0.4833 |
Loa Loa (eye worm) | hypothetical protein | 0.0214 | 0.3038 | 0.3038 |
Trichomonas vaginalis | pyruvate, phosphate dikinase, chloroplast, putative | 0.026 | 0.3825 | 0.1256 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.3671 | 0.3671 |
Toxoplasma gondii | pyruvate kinase PyKII | 0.0319 | 0.4833 | 0.4833 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0327 | 0.0327 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0327 | 0.0327 |
Echinococcus multilocularis | pyruvate kinase | 0.0319 | 0.4833 | 0.4833 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0327 | 0.0327 |
Trichomonas vaginalis | pyruvate, phosphate dikinase, chloroplast, putative | 0.026 | 0.3825 | 0.1256 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.3671 | 0.3671 |
Echinococcus multilocularis | pyruvate kinase | 0.0491 | 0.7764 | 0.7764 |
Loa Loa (eye worm) | pyruvate kinase | 0.0131 | 0.1622 | 0.1622 |
Trichomonas vaginalis | pyruvate, phosphate dikinase, chloroplast, putative | 0.026 | 0.3825 | 0.1256 |
Echinococcus granulosus | pyruvate kinase | 0.0319 | 0.4833 | 0.4833 |
Trichomonas vaginalis | pyruvate, phosphate dikinase, chloroplast, putative | 0.026 | 0.3825 | 0.1256 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.4263 | 0.1877 |
Entamoeba histolytica | pyruvate kinase, putative | 0.0434 | 0.6788 | 1 |
Brugia malayi | pyruvate kinase, muscle isozyme | 0.0131 | 0.1622 | 0.1622 |
Loa Loa (eye worm) | pyruvate kinase-PB | 0.0434 | 0.6788 | 0.6788 |
Trichomonas vaginalis | pyruvate, phosphate dikinase, chloroplast, putative | 0.026 | 0.3825 | 0.1256 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0327 | 0.0327 |
Loa Loa (eye worm) | hypothetical protein | 0.0434 | 0.6788 | 0.6788 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0067 | 0.0522 | 0.0522 |
Onchocerca volvulus | 0.0286 | 0.4263 | 0.4263 | |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0327 | 0.0327 |
Echinococcus granulosus | pyruvate kinase | 0.0319 | 0.4833 | 0.4833 |
Trichomonas vaginalis | pyruvate, phosphate dikinase, chloroplast, putative | 0.026 | 0.3825 | 0.1256 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0327 | 0.0327 |
Wolbachia endosymbiont of Brugia malayi | pyruvate phosphate dikinase | 0.026 | 0.3825 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0327 | 0.0327 |
Brugia malayi | Voltage-gated calcium channel, T-type, alpha subunit. C. elegans cca-1 ortholog | 0.0214 | 0.3038 | 0.3038 |
Echinococcus multilocularis | pyruvate kinase | 0.0319 | 0.4833 | 0.4833 |
Plasmodium vivax | pyruvate kinase 2, putative | 0.0319 | 0.4833 | 0.4833 |
Treponema pallidum | pyruvate phosphate dikinase | 0.026 | 0.3825 | 0.5 |
Echinococcus granulosus | pyruvate kinase | 0.0319 | 0.4833 | 0.4833 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0327 | 0.0327 |
Trichomonas vaginalis | pyruvate, phosphate dikinase, chloroplast, putative | 0.026 | 0.3825 | 0.1256 |
Trichomonas vaginalis | phosphoenolpyruvate-protein phosphotransferase, putative | 0.026 | 0.3825 | 0.1256 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0327 | 0.0327 |
Trichomonas vaginalis | phosphoenolpyruvate-protein phosphotransferase, putative | 0.026 | 0.3825 | 0.1256 |
Trichomonas vaginalis | phosphoenolpyruvate-protein phosphotransferase, putative | 0.026 | 0.3825 | 0.1256 |
Schistosoma mansoni | pyruvate kinase | 0.0319 | 0.4833 | 0.4833 |
Brugia malayi | Pyruvate kinase, alpha/beta domain containing protein | 0.0188 | 0.2597 | 0.2597 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0067 | 0.0522 | 0.0522 |
Brugia malayi | pyruvate kinase | 0.0131 | 0.1622 | 0.1622 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | 5.67 uM | PUBCHEM_BIOASSAY: Inhibitors of T-Type Calcium Channel. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID449739, AID463087, AID493021, AID493022, AID493023, AID493041, AID504579, AID504584, AID504619, AID504628] | ChEMBL. | No reference |
Potency (functional) | 3.1623 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 4.4668 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Anthrax Lethal Toxin Internalization. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Saccharomyces cerevisiae | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.